Table 6:
CC | MICE | SIPW | |
---|---|---|---|
CSHRa (p-Value) | CSHRa (p-Value) | CSHRa (p-Value) | |
Time on ART (per six months) | 0.64 (<0.001) | 0.80 (0.154) | 0.62 (<0.001) |
Gender | |||
Female & non-pregnant | 1.00 (−) | 1.00 (−) | 1.00 (−) |
Female & pregnant | 0.52 (0.057) | 1.07 (0.883) | 0.52 (0.073) |
Male | 0.90 (0.476) | 1.07 (0.691) | 0.99 (0.937) |
Ageb (per 10 years) | 1.05 (0.565) | 1.00 (0.998) | 1.03 (0.798) |
CD4b (per 100 cell/μL) | 0.72 (<0.001) | 0.79 (0.093) | 0.72 (<0.001) |
HIV status disclosed | 0.84 (0.250) | 0.85 (0.368) | 0.83 (0.252) |
Travel time to clinic >30′ | 1.26 (0.221) | 1.69 (0.037) | 1.40 (0.098) |
Level of care | |||
Secondary/Tertiary | 1.00 (−) | 1.00 (−) | 1.00 (−) |
Primary | 0.66 (0.022) | 0.48 (0.098) | 0.50 (<0.001) |
Cause-specific hazard ratio.
At ART initiation.